1. Dr. Hans-Joachim Schmoll. Expert op het gebied van darmkanker. Biografie. 0
Dr. Hans-Joachim Schmoll, MD, explains his extensive career and contributions to cancer medicine. He is a professor and director of clinical oncology research in Germany....
▶⏸
2. Darmkanker screening. Welke test is het meest effectief? Deel 1 van 2. Colonoscopie. 1-1
Dr. Hans-Joachim Schmoll, MD, explains how colon cancer screening saves lives. He details the effectiveness of colonoscopy for early detection.
▶⏸
3. Stadiëring van colorectale kanker. Moleculaire kankerclassificatie voor precisiebehandeling van tumoren. 2-1
Dr. Hans-Joachim Schmoll, MD, explains how molecular classification is transforming colon cancer treatment. He details the limitations of current staging systems for stage II and...
▶⏸
4. Colorectale kankerstamcellen. Immunotherapie van darmkanker. 3-1
Dr. Hans-Joachim Schmoll, MD, explains the critical role of cancer stem cells in treatment resistance and metastasis. He details how these cells evade chemotherapy and...
▶⏸
5. Precisie chemotherapie van colorectale kanker. EGFR, BRAF, MEK-remmers. 4-1
Dr. Hans-Joachim Schmoll, MD, explains how to use mutations in EGFR, BRAF, and MEK pathways to select a personalized treatment plan. He details the efficacy...
▶⏸
6. Prognose van colorectale kanker. Adaptieve klinische proeven. Voorspelling van de respons op de behandeling. 8-1
Dr. Hans-Joachim Schmoll, MD, explains how precision medicine and molecular tumor profiling are reshaping colon cancer prognosis. He details the shift from traditional staging to...
▶⏸
7. De kwaliteit van de behandeling van colorectale kanker varieert sterk. 9-1
Dr. Hans-Joachim Schmoll, MD, explains how treatment quality varies globally. He details the critical role of multidisciplinary teams in creating optimal treatment plans.
▶⏸
8. Darmkanker screening. Welke test is het meest effectief? Tumor-DNA-tests van uitwerpselen en bloed. Deel 2 van 2. 1-2
Dr. Hans-Joachim Schmoll, MD, explains how traditional fecal occult blood tests only detect intermediate or advanced stage cancers. He details the evolution to more sensitive...
▶⏸
9. Precisiebehandeling van darmkanker. Het genetische profiel van de patiënt is belangrijk. 2-2
Dr. Hans-Joachim Schmoll, MD, explains how a patient's own genetic profile is critical for treatment personalization. He details recent clinical trial data showing germline mutations...
▶⏸
10. Colorectale kanker immunotherapie. Welke patiënten profiteren het meest? 3-2
Dr. Hans-Joachim Schmoll, MD, explains how immunotherapy activates the body's immune system to attack tumors. He details that immune checkpoint inhibitors are highly effective for...
▶⏸
11. Behandeling van colorectale kanker met HER2-remmers. Herceptin en Lapatinib (Tykerb). 4-2
Dr. Hans-Joachim Schmoll, MD, explains HER2 inhibitors for colon cancer treatment. He details how trastuzumab (Herceptin) and lapatinib (Tykerb) target HER2-positive tumors. This dual inhibition...
▶⏸
12. Voorspelling van de werkzaamheid van Capecitabine (Xeloda) therapie. DPD-enzymgenexpressie bij darmkanker. 5-2
Dr. Hans-Joachim Schmoll, MD, explains how the DPD enzyme predicts treatment response. DPD gene expression in a colon cancer tumor is a strong biomarker for...
▶⏸
13. Vloeibare biopsie bij colorectale kanker. Precisie diagnose en behandeling. 8-2
Dr. Hans-Joachim Schmoll, MD, explains how liquid biopsy transforms cancer monitoring. This advanced technique analyzes tumor DNA and RNA from a simple blood draw. It...
▶⏸
14. Elke kankerpatiënt moet worden beoordeeld door Tumor Board. Multidisciplinair team. 9-2
Dr. Hans-Joachim Schmoll, MD, explains the critical importance of a Multidisciplinary Team (MD T) or Tumor Board for every cancer patient. He details how this...
▶⏸
15. Stadium 3 behandeling van darmkanker. Capecitabine (Xeloda) en 5-Fluorouracil (5-FU). 5-1
Dr. Hans-Joachim Schmoll, MD, explains stage 3 colon cancer therapy. He details the critical role of optimal surgery and lymph node removal.
▶⏸
16. Chemotherapie van rectumkanker. Capecitabine (Xeloda) en oxaliplatine 5-FU. Controverses. 5-3
Dr. Hans-Joachim Schmoll, MD, explains the role of chemotherapy in rectal cancer treatment. He details how chemotherapy and radiotherapy can sometimes eradicate tumors before surgery....
Dr. Hans-Joachim Schmoll, MD, explains advanced treatment options for stage 4 colon cancer with liver or lung metastases. He details how systemic chemotherapy can convert...
▶⏸
18. Colorectale kankerchemotherapie bij ouderen. Kies een behandeling op basis van fitness. 6
Dr. Hans-Joachim Schmoll, MD, explains how to choose chemotherapy for elderly patients. Over half of colorectal cancer cases are diagnosed in patients over 70. Treatment...
▶⏸
19. Rectale kankertherapie zonder operatie. Toekomst van de behandeling van colorectale kanker. 10
Dr. Hans-Joachim Schmoll, MD, explains how rectal cancer treatment is evolving. Chemotherapy and radiation can sometimes eradicate rectal tumors completely. This allows select patients to...
Verfijn uw behandelplan tot in de puntjes door een panel van 3 tot 10+ topartsen die perfect bij u passen.
